Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T22:11:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the site header, replacing the previously visible study details and links. This indicates the study record is currently inaccessible.
    Difference
    21%
    Check dated 2026-09-30T22:28:31.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a Home link, indicating the study record is not accessible. The surrounding navigation and header remain, but detailed study content is not visible.
    Difference
    21%
    Check dated 2026-09-23T21:50:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a software/maintenance update to the page. This update does not change study details or information presented.
    Difference
    0.0%
    Check dated 2026-09-16T22:14:58.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a refreshed or republished version of the page.
    Difference
    0.0%
    Check dated 2026-09-02T20:08:03.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The study's identifiers now include a reference to a 2018 U.S. NIH grant/contract, indicating NIH funding associated with this trial.
    Difference
    0.0%
    Check dated 2026-08-26T19:44:14.000Z thumbnail image

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.